Wassim H. Fares, MD, MS, is the director of Yale Medicine’s Pulmonary Vascular Disease Program. He specializes in evaluating and managing patients at different stages of pulmonary hypertension.
Dr. Fares says early detection of pulmonary hypertension is crucial for patients. “If diagnosed early, we have many treatments that can slow the progression of the disease and help you live a normal active life,” he says. Those treatments may include oral, inhaled and/or infused therapies.
Patients in his program, which is the only one in the state accredited by the national Pulmonary Hypertension Association, benefit from comprehensive, multidisciplinary care, he says. “We are fully committed to making you and your family comfortable, whether in the inpatient or outpatient setting,” he says. Dr. Fares’ clinical and research interests also include heart-lung interactions, connective tissue diseases (including scleroderma and lupus) and hereditary hemorrhagic telangiectasias (HHT). He is an assistant professor of medicine (pulmonary) at Yale School of Medicine.